Bioventus Class A Inc (BVS)
$13.32 -10.39% Close Oct 30, 2026 Live
Bioventus Class A stock today
Bioventus Class A closed at $13.32 on October 30, 2026, down 10.39% on the day. Over the past year it returned +96.8% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $1.11 billion.
$10.00$15.00
NovJan 2026MarMayJulSep
| Period | BVS | S&P 500 (SPY) |
|---|---|---|
| 1 month | -2.2% | -0.9% |
| 3 months | +1.1% | +2.1% |
| Year to date | +79.1% | +11.7% |
| 1 year | +96.8% | +12.4% |
| 3 years | +276.4% | +88.5% |
| 5 years | -11.8% | +76.0% |
Key statistics
- Market value
- $1.11B
- P/E (trailing)
- 17.3
- Forward P/E
- 15.7
- Price / sales
- 1.9
- 52-week range
- $6.53 to $15.26
- Next report
- Nov 2, 2026
About Bioventus Class A
Bioventus develops and sells biologics and orthopedic treatments for joint preservation and regeneration.
Sector: Health Care
More on Bioventus Class A
- Financials: revenue, earnings and segmentsRevenue -1% in the year to Dec 2025
- Valuation: P/E history and peersP/E 17.3
- Returns: what $1,000 became$1,000 five years ago is $882.45 today
No forecast, no recommendation. This page describes Bioventus Class A Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.